Rhu-pGSN to Mitigate Proinflammatory Responses to Decompression in Healthy SCUBA Divers

Conditions: Decompression Sickness Interventions: Drug: Sodium Chloride 0.9% Inj pre-exposure; Drug: Sodium Chloride 0.9% Inj post-exposure; Drug: Recombinant human plasma gelsolin pre-exposure; Drug: Recombinant human plasma gelsolin post-exposure; Other: Hyperbaric chamber Sponsors: BioAegis Therapeutics Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials